UICC Opens the World Cancer Leaders’ Summit 2025

World Cancer Leaders UICC

“Delivering Innovation with Integrity” - ACT 4 Children Initiative at the 2025 WCLS

ACT 4 Children

Top Growing Medical Universities in USA and Canada: 2025 Edition by BIGR

USA and Canada

2025 Selected Abstracts for the European Cancer Summit - European Cancer Organisation

European Cancer Organisation European Cancer Summit

The World’s First Trial of a Vaccine to Prevent Lung Cancer - Cancer Research UK

Cancer Research UK

Pediatric Cardio-Oncology Consortium to Host Virtual Summit on December 4, 2025

Cardio-Oncology-Consortium

10 Oncology Experts Join OncoDaily Medical Journal’s Editorial Team

OncoDaily Medical Journal

FDA Approves Ziftomenib (Komzifti) for Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia

ziftomenib

OncoCalendar

« All Events

Overactivation of Oncogenic Signalling as a Potential Cancer Treatment Strategy

Jan 20, 2026 - Jan 21, 2026
Oncogenic Signalling

The European Association for Cancer Research (EACR) conference, “Overactivation of Oncogenic Signalling as a Potential Cancer Treatment Strategy,” is a Virtual Event scheduled for January 20-21, 2026. This conference explores a paradoxical and radically different approach to cancer therapy: instead of inhibiting the signals that drive cancer, it focuses on the deliberate hyper-activation of oncogenic signaling pathways.

Accumulating evidence suggests that excessive stimulation can lead to cancer cell death by causing a further activation of cellular stress responses. The meeting, chaired by Rene Bernards, aims to give the audience a fundamentally different perspective on treating advanced cancers where conventional inhibition strategies have failed, by focusing on drugs that activate oncogenic signaling and the resulting vulnerabilities of cancer cells.

Details

Organizer